Cambridge Nutritional Sciences (LON:CNSL) Insider Jeremy Millard Acquires 168,776 Shares

Cambridge Nutritional Sciences plc (LON:CNSL) insider Jeremy Millard acquired 168,776 shares of the business’s stock in a transaction on Tuesday, November 18th. The stock was acquired at an average price of GBX 2 per share, with a total value of £3,375.52.

Cambridge Nutritional Sciences Trading Up 11.1%

Shares of CNSL opened at GBX 2.50 on Wednesday. Cambridge Nutritional Sciences plc has a twelve month low of GBX 1.86 and a twelve month high of GBX 4.38. The firm has a market capitalization of £5.95 million, a P/E ratio of 3.57 and a beta of 3.89. The firm’s 50-day moving average is GBX 2.73 and its two-hundred day moving average is GBX 3.08.

Cambridge Nutritional Sciences (LON:CNSL) last released its quarterly earnings results on Monday, November 10th. The company reported GBX (0.20) earnings per share for the quarter. Cambridge Nutritional Sciences had a negative return on equity of 3.34% and a negative net margin of 3.36%. Analysts predict that Cambridge Nutritional Sciences plc will post 0.036865 EPS for the current year.

About Cambridge Nutritional Sciences

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.